Outcome Capital shares their views, insights and data on key strategic trends and dynamics in the Medical Device sector.
Market Insight: Thomas Busby and Oded Ben-Joseph, PhD
Outcome Capital shares their views, insights and data on key strategic trends and dynamics in the Medical Device sector.
Macroeconomic uncertainty, confusion surrounding the diagnostic regulatory landscape, and the continuing post-COVID-19 pandemic hangover have all contributed to a stagnant, quiet period for mergers and acquisitions in the in vitro diagnostics space in the first half of 2024.
Read MoreOutcome Capital Life Science Market Pulse June 2024 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?